No definition available.
Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)
C3_STOMACH_NEUROENDOCRINE_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
160 |
4. Check minimum number of eventsNone |
160 |
5. Include endpointsNone |
160 |
6. Filter based on genotype QC (FinnGen only) |
160 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Neuroendocrine tumor and carcinoma of stomach
- Malignant neoplasm of stomach
- Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 160 | 84 | 76 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 62.11 | 59.36 | 65.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 149
- Matched controls
- 1491
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K29.4
ICD-10 Finland
Chronic atrophic gastritis
110.3
82.7
86
18
8240/3-C16.9
ICD-O-3
Neuroendocrine tumor, NOS, of stomach, NOS
+∞
78.2
68
*
B03BA03
ATC
hydroxocobalamin; parenteral
51.2
78.0
97
52
107
Kela drug reimbursment
Pernicious anaemia
61.2
59.1
68
20
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
21.5
56.7
124
279
B81
ICPC
Anaemia vit B12/folate deficiency
40.1
51.3
65
28
8240/3-C16.2
ICD-O-3
Neuroendocrine tumor, NOS, of body of stomach
+∞
46.3
42
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
43.1
46.1
57
21
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
534.2
42.4
40
*
130
Kela drug reimbursment
Malignant tumour
+∞
26.9
25
*
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
74.4
22.6
25
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
15.9
15
*
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
15.9
15
*
UJD02
NOMESCO Finland
Gastroscopy
10.9
14.5
28
31
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
+∞
13.8
13
*
A50
ICPC
General and Unspecified, Medication/prescr/renewal
13.4
12.3
21
18
JDA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in stomach or pylorus
+∞
10.5
10
*
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
35.3
10.5
13
*
UJF32
NOMESCO Finland
Coloscopy
3.5
10.5
59
233
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
21.9
10.0
14
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
19.1
9.6
14
8
H02AB02
ATC
dexamethasone; systemic
23.5
9.5
13
6
8240/3-C16.0
ICD-O-3
Neuroendocrine tumor, NOS, of cardia, NOS
+∞
9.5
9
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
29.5
8.6
11
*
H01CB02
ATC
octreotide; parenteral
+∞
8.4
8
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.3
8.2
25
55
A10AE04
ATC
insulin glargine; parenteral
4.7
7.9
27
67
D64.9
ICD-10 Finland
Anaemia, unspecified
4.5
7.6
27
70
C61
ICD-10 Finland
Malignant neoplasm of prostate
84.1
7.5
8
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
7.3
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
-50
ICPC
Medication/prescr/renewal
6.7
7.0
17
28
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
42.0
6.8
8
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.9
6.7
21
48
H03AA01
ATC
levothyroxine sodium; systemic
2.7
6.5
50
232
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
19.0
6.3
9
5
S50
ICPC
Skin, Medication/prescr/renewal
28.0
6.3
8
*
8249/3-C16.9
ICD-O-3
Neuroendocrine tumor, grade 2 of stomach, NOS
+∞
6.3
6
*
8249/3-C16.2
ICD-O-3
Neuroendocrine tumor, grade 2 of body of stomach
+∞
6.3
6
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
6.2
40
164
JN4AD
NOMESCO Finland
Body CT examination
6.3
6.0
15
26
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
61
30
32.25
84.44
2.3
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
87
173
9.83
48.13
3.3
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
25
0
+∞
26.82
3.1
0.0
pmol/l
273.9
—
—
19
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
75
318
3.56
13.93
3.2
2.0
mg/l
3.5
3.3
0.27
67
264
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
32
74
5.16
13.60
2.9
1.3
ug/l
13.8
6.5
0.38
26
55
(3024561) Albumin [Mass/volume] in Serum or Plasma
95
531
2.94
10.13
5.8
3.2
g/l
34.4
35.4
0.89
87
493
(3032080) INR in Blood by Coagulation assay
91
498
2.92
10.08
7.7
9.5
inr
1.1
1.3
2.10
22
137
(3001122) Ferritin [Mass/volume] in Serum or Plasma
88
487
2.79
9.33
4.5
2.6
ug/l
86.7
115.8
0.49
81
444
(3022948) Iron [Moles/volume] in Serum or Plasma
47
185
3.18
9.33
2.7
2.3
umol/l
12.3
13.1
0.12
42
168
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
42
158
3.25
8.95
2.5
2.4
%
19.3
22.0
0.28
36
140
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
96
570
2.71
8.64
3.0
2.0
pmol/l
81.8
93.7
1.36
60
282
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
102
638
2.65
8.05
7.4
3.7
umol/l
11.1
11.8
0.42
96
593
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
59
284
2.71
7.97
2.5
1.7
pmol/l
650.0
435.2
1.14
48
232
(3013650) Neutrophils [#/volume] in Blood by Automated count
100
650
2.44
6.82
10.2
6.2
e9/l
4.6
4.3
0.42
87
554
(3019198) Lymphocytes [#/volume] in Blood
94
595
2.41
6.80
6.0
5.4
e9/l
1.6
1.9
2.50
84
520
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
96
619
2.38
6.58
6.4
5.3
mmol/l
1.2
1.2
0.08
80
524
(3018010) Neutrophils/100 leukocytes in Blood
87
544
2.31
6.33
6.2
5.4
%
60.8
57.5
1.51
82
498
(42870588) Differential panel, method unspecified - Blood
69
392
2.34
6.27
6.3
5.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
88
561
2.26
6.01
6.0
4.9
mmol/l
1.2
1.2
0.13
81
493
(3021960) Folate [Moles/volume] in Serum or Plasma
59
320
2.34
5.91
1.7
1.5
nmol/l
26.2
21.4
1.16
53
268
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
81
506
2.22
5.74
3.8
3.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
30
124
2.75
5.27
1.4
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
66
391
2.17
5.23
2.2
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
88
587
2.11
5.08
6.1
5.3
e9/l
0.6
0.6
0.18
79
502
(3006315) Basophils [#/volume] in Blood
88
588
2.10
5.05
6.2
5.3
e9/l
0.0
0.0
0.32
79
503
(3044640) Blood type and Crossmatch panel - Blood
60
347
2.17
5.02
2.8
2.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
89
603
2.07
4.85
6.6
5.5
e9/l
0.2
0.2
0.14
80
523
(3002256) Pathology report gross observation
23
86
2.96
4.83
1.3
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
258
2.23
4.78
2.5
2.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
50
275
2.19
4.70
2.1
1.7
nmol/l
1065.0
1200.9
0.56
37
207
(3018418) pH of Serum or Plasma
61
366
2.08
4.56
4.0
3.3
ph
7.4
7.4
0.03
14
58
(3015377) Calcium [Moles/volume] in Serum or Plasma
64
392
2.05
4.52
3.8
2.0
mmol/l
2.3
2.4
0.21
54
315
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
98
2.70
4.29
1.1
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
53
308
2.08
4.27
4.6
3.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
32
3.97
4.17
1.3
1.2
ug/g
274.4
319.1
—
7
17
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
94
2.69
4.10
1.1
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
76
509
1.94
4.07
2.8
2.2
nmol/l
80.0
77.7
0.23
69
435
(3027945) Reticulocytes/100 erythrocytes in Blood
30
149
2.25
3.55
2.3
2.4
%
1.7
1.6
0.11
25
136
(3026493) Urate [Moles/volume] in Serum or Plasma
52
330
1.85
3.13
2.1
2.5
umol/l
334.0
9038.2
2.07
41
285
(3022313) Gas panel - Capillary blood
14
52
2.85
2.97
4.0
4.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
44
277
1.81
2.68
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
106
853
1.72
2.64
5.7
4.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
36
214
1.88
2.62
1.2
1.3
iu/ml
15.0
42.8
—
10
70
(3007164) IgA [Mass/volume] in Serum or Plasma
38
230
1.86
2.61
1.4
1.3
g/l
2.7
2.7
0.02
23
140
(3026008) Bacteria identified in Urine by Culture
56
382
1.72
2.58
3.6
3.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
27
146
2.02
2.57
1.3
1.4
titre
324.4
614.4
—
9
39
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
11
5.62
2.56
1.7
1.6
u/ml
2.7
338.9
—
6
11
(3004451) EKG impression Narrative
5
7
7.32
2.56
1.0
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
52
2.63
2.42
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
23
120
2.07
2.40
4.1
3.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
8
6.41
2.39
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
38
241
1.76
2.23
3.8
2.2
mmol/l
2.5
2.4
0.68
30
203
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
74
2.29
2.23
1.9
1.7
—
—
—
0
0
(3013512) EKG study
55
388
1.64
2.18
3.7
4.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
10
37
2.82
2.14
1.1
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
98
799
1.58
2.09
3.9
2.9
u/l
68.2
44.8
1.09
90
739
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
41
274
1.67
1.99
1.4
1.7
mg/l
1.5
1.1
0.19
30
217
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
19
100
2.02
1.95
2.8
4.1
ng/l
89.8
82.4
0.23
19
88
(3009508) Creatinine [Moles/volume] in Urine
59
434
1.57
1.94
4.0
3.0
mmol/l
6.3
7.6
1.06
45
362
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
46
2.49
1.89
1.5
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
116
1.93
1.89
1.3
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
21
117
1.91
1.85
2.0
2.5
e9/l
68.6
64.8
0.23
15
90
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
38
254
1.65
1.84
1.4
1.2
u/ml
0.7
1.7
—
8
75
(3042631) Mycobacterium sp identified in Specimen
5
12
4.26
1.83
6.4
3.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
29
2.85
1.82
3.8
3.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
54
2.32
1.79
1.1
1.5
—
—
—
0
0
(4094501)
9
36
2.59
1.77
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
79
630
1.50
1.76
4.7
3.8
estimate
0.0
0.0
0.00
14
97
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
112
962
1.55
1.73
5.8
3.7
pmol/l
15.3
14.9
1.03
102
856
(3007853) Bacteria identified in Skin by Aerobe culture
24
143
1.80
1.73
2.9
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
13
3.93
1.73
1.2
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
78
622
1.50
1.72
5.5
5.2
estimate
0.0
0.0
0.00
15
101
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
38
258
1.62
1.72
5.6
4.0
ng/l
120.8
169.8
0.23
31
213
(3035350) Ketones [Presence] in Urine by Test strip
77
614
1.49
1.70
4.6
3.8
estimate
0.0
0.0
0.00
14
101
(3020682) Albumin/Creatinine [Ratio] in Urine
60
455
1.51
1.68
4.8
3.8
mg/mmol
59.3
6.1
0.53
35
277
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
31
2.66
1.68
1.0
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
31
2.66
1.68
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
19
3.24
1.67
1.3
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
19
3.24
1.67
1.3
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
56
2.24
1.65
5.6
8.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
29
423
0.62
1.56
3.8
3.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
79
1.99
1.55
1.1
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
27
2.66
1.53
2.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
88
1.91
1.47
1.1
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
7
28
2.57
1.47
1.9
1.4
—
0.1
—
0
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
39
2.38
1.45
1.2
2.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
57
442
1.45
1.39
3.2
3.1
ng/l
1583.7
1549.3
0.03
48
373
(3012516) Albumin [Mass/volume] in Urine
55
424
1.45
1.38
4.1
3.1
mg/l
68.3
196.9
0.38
33
266
(40760888) Immunoglobulin light chains.free panel - Serum
6
23
2.67
1.38
1.2
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
10
47
2.20
1.37
3.6
5.3
mmol/l
24.7
26.0
—
10
41
(3021589) Normoblasts [#/volume] in Blood
66
528
1.43
1.36
11.7
8.4
e9/l
0.0
0.0
0.44
56
416
(40760892) CBC W Ordered Manual Differential panel - Blood
35
247
1.53
1.35
5.4
5.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
84
1.87
1.32
2.3
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
24
2.56
1.31
1.0
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
28
189
1.58
1.30
2.0
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
57
447
1.43
1.30
4.3
3.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
69
562
1.40
1.27
3.7
3.9
ng/l
194.0
42.9
0.45
52
409
(3018677) aPTT in Platelet poor plasma by Coagulation assay
28
191
1.56
1.25
1.7
1.8
s
29.1
29.1
0.00
28
185
(3000850) Epithelial cells [#/volume] in Urine
36
262
1.48
1.20
2.7
2.2
e6/l
4.6
4.7
0.01
29
224
(3042936) Bacteria identified in Isolate by Culture
26
177
1.56
1.17
2.5
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
56
446
1.39
1.15
5.6
3.7
e6/l
421.4
113.2
0.35
41
319
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
128
1.64
1.15
2.1
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
22
146
1.59
1.10
1.5
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
28
197
1.51
1.10
1.4
1.3
u/ml
1.2
16.9
—
8
72
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
130
1.62
1.09
2.1
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
83
1.75
1.05
1.1
1.2
—
—
—
0
0
(3015736) pH of Urine
60
492
1.35
1.02
3.5
3.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
29
0.00
0.99
0.0
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
43
336
1.38
0.98
4.0
2.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
117
1264
0.72
0.98
5.4
4.7
mmol/l
1.4
1.5
1.07
106
1154
(3002582) Erythrocytes [#/volume] in Urine
48
382
1.37
0.98
4.6
3.1
e6/l
677.0
216.6
0.31
38
290
(3000991) Gas panel - Venous blood
16
101
1.65
0.98
4.7
7.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
31
0.00
0.97
0.0
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
42
330
1.37
0.93
4.0
3.5
—
—
—
0
0
(3000492) Spirometry study
17
111
1.59
0.92
2.0
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
71
1.75
0.91
2.6
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
64
1.77
0.88
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
113
1221
0.75
0.88
4.7
4.3
mmol/l
1.3
1.3
0.09
100
1105
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
15
96
1.62
0.88
2.3
2.4
mmol/l
1.2
1.2
0.54
15
80
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
44
1.86
0.87
1.8
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
57
1.80
0.85
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
130
1.52
0.85
3.4
3.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
38
298
1.36
0.85
4.4
3.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
122
1.54
0.84
1.6
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
32
244
1.39
0.84
2.7
2.7
mosm/kgh2o
527.3
550.2
0.34
25
199
(3003396) Base excess in Arterial blood by calculation
20
139
1.50
0.84
4.9
5.8
mmol/l
-0.3
1.5
1.11
13
105
(36660697) Celiac disease serology panel - Serum
13
81
1.66
0.84
1.4
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
32
1.91
0.82
1.8
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
41
328
1.34
0.81
5.8
4.0
estimate
0.0
0.0
0.00
14
101
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
48
1.70
0.80
1.0
1.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
6
33
1.85
0.80
1.0
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
119
1271
0.75
0.79
5.4
4.8
mmol/l
4.2
4.6
3.02
108
1164
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
27
0.00
0.78
0.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
34
1.79
0.77
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
34
1.79
0.77
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
0
28
0.00
0.77
0.0
1.2
—
2.5
—
0
22
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
0
28
0.00
0.77
0.0
1.4
—
96.8
—
0
22
(3024354) Oxygen [Partial pressure] in Venous blood
17
117
1.51
0.75
2.5
2.8
kpa
4.3
4.4
0.06
17
111
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
122
1296
0.75
0.75
6.1
5.4
mmol/l
2.4
2.7
2.78
111
1184
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
57
485
1.27
0.71
4.7
3.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
26
1.95
0.71
1.0
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
41
1.74
0.71
1.6
1.7
g/l
0.2
0.2
—
7
41
(3022217) INR in Platelet poor plasma by Coagulation assay
25
189
1.38
0.70
18.1
23.2
inr
1.4
1.3
—
7
22
(40761536) Microorganisms panel - Urine sediment
14
94
1.54
0.69
3.9
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
132
1246
1.34
0.68
22.6
12.7
mg/l
27.0
22.5
0.83
118
944
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
7
43
1.66
0.67
1.6
1.7
g/l
1.2
1.2
—
7
43
(3019060) Gas panel - Arterial blood
12
78
1.58
0.67
3.8
3.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
29
1.75
0.64
1.6
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
71
1.59
0.64
4.6
6.3
mmol/l
25.0
25.3
0.08
11
71
(3030467) Casts [#/volume] in Urine by Automated count
43
358
1.28
0.63
4.0
2.9
e6/l
2.5
0.6
0.83
32
259
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
49
1.67
0.63
1.8
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
51
1.60
0.61
1.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
20
0.00
0.61
0.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
35
1.74
0.58
1.7
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
88
0.55
0.58
2.0
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
37
1.65
0.56
1.7
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
37
1.65
0.56
1.0
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
61
1.50
0.55
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
100
925
1.22
0.54
4.3
4.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
9
62
1.48
0.54
5.2
8.1
mmol/l
24.1
25.1
—
9
53
(3012544) pH of Venous blood
19
145
1.35
0.51
2.7
3.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
26
209
1.29
0.50
5.2
3.0
e6/l
2.3
2.8
0.13
14
109
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
124
1180
1.23
0.46
6.9
4.6
mu/l
1.8
2.0
0.54
116
1044
(3014051) Protein [Presence] in Urine by Test strip
5
31
1.63
0.43
4.6
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
56
1.45
0.43
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
32
1.58
0.42
1.2
2.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
71
647
1.18
0.42
3.1
2.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
41
356
1.20
0.42
3.4
3.9
%
20.1
24.7
1.42
16
168
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
15
0.00
0.41
0.0
2.7
—
563.6
—
0
10
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
34
1.49
0.40
1.0
1.1
—
—
—
0
0
(4010399)
13
98
1.36
0.39
1.5
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
265
1.21
0.37
2.3
2.8
ug/l
0.9
0.8
0.15
21
172
(1002224) Polysomnography panel
6
46
1.32
0.33
1.0
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
10
75
1.36
0.31
5.8
8.0
%
94.0
93.3
—
10
75
(3045414) Leukocytes [Presence] in Urine
7
55
1.29
0.30
5.1
1.9
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
77
1.32
0.27
1.4
2.3
%
1.1
1.3
—
10
77
(3001019) Free T4 and TSH panel - Serum or Plasma
5
37
1.36
0.24
1.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
172
1.19
0.23
9.4
7.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
41
1.23
0.22
1.2
1.1
g/l
0.0
0.0
—
5
41
(4027681)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
1.0
—
0
10
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
102
1057
0.90
0.21
31.4
16.3
g/l
328.5
331.7
1.95
102
1050
(3000963) Hemoglobin [Mass/volume] in Blood
136
1388
0.87
0.21
35.5
18.7
g/l
128.9
135.8
5.73
136
1354
(3019550) Sodium [Moles/volume] in Serum or Plasma
136
1330
1.15
0.21
26.3
15.4
mmol/l
139.2
139.9
2.25
136
1279
(3023410) Appearance of Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
13
0.00
0.21
0.0
5.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
26
232
1.14
0.20
4.5
2.7
e6/l
1.2
1.2
0.04
14
130
(3035941) MCH [Entitic mass]
136
1387
0.87
0.20
35.1
18.5
pg
29.7
30.4
3.22
136
1355
(3020564) Creatinine [Moles/volume] in Serum or Plasma
136
1332
1.14
0.19
27.1
15.0
umol/l
79.5
80.0
0.05
136
1332
(3024731) MCV [Entitic volume]
136
1386
0.87
0.19
35.1
18.6
fl
90.2
91.4
2.30
136
1354
(40758558) Short blood count panel - Blood
32
292
1.12
0.18
5.5
4.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
136
1333
1.14
0.18
26.4
15.5
mmol/l
3.9
4.0
2.52
136
1280
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
122
1192
1.10
0.16
23.6
11.8
ml/min/173m2
77.9
75.1
0.73
108
960
(40761511) CBC panel - Blood by Automated count
130
1325
0.90
0.16
21.0
11.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
13
113
1.16
0.13
3.8
2.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
96
1.16
0.10
4.7
3.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
48
1.04
0.09
1.2
1.1
g/l
36.9
38.5
—
5
43
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
56
1.07
0.09
2.0
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5
64
0.77
0.08
2.4
2.9
pmol/l
4.4
4.4
—
5
54
(3000330) Specific gravity of Urine by Test strip
8
78
1.03
0.07
4.0
4.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
18
167
1.09
0.07
4.7
4.7
%
38.6
31.9
1.66
11
102
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
124
1228
1.04
0.04
9.1
6.3
mmol/mol
43.9
40.8
2.05
117
1135
(3019150) Specific gravity of Urine by Refractometry
30
294
1.03
0.00
5.5
3.8
kg/l
1.0
1.0
—
7
48
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
127
1273
0.99
0.00
6.5
4.9
mmol/l
6.5
6.1
1.85
121
1148
(3009542) Hematocrit [Volume Fraction] of Blood
111
1108
1.01
0.00
24.4
13.9
%
37.6
40.2
1.30
74
747
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
46
462
0.99
0.00
4.5
4.0
ug/l
6.4
2.1
0.62
40
407
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
16
165
0.97
0.00
1.6
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
155
1.04
0.00
1.4
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
50
1.00
0.00
2.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.1
—
9.3
—
0
7
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
3.0
—
13.9
—
0
5
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
9
0.00
0.00
0.0
4.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
69
1.02
0.00
1.4
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.7
—
975.2
—
0
6
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
0.00
0.0
1.4
—
213.8
—
0
5
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
636.4
—
0
5
(3028433) Virus identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
212.5
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
10.7
—
1723.0
—
0
6
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
1.6
—
0
6
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(4034850)
5
57
0.87
0.00
20.4
10.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_STOMACH_NEUROENDOCRINE_EXALLC – Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).